M
Mary Jo O'Sullivan
Researcher at University of Miami
Publications - 264
Citations - 36304
Mary Jo O'Sullivan is an academic researcher from University of Miami. The author has contributed to research in topics: Pregnancy & Gestational age. The author has an hindex of 82, co-authored 263 publications receiving 34143 citations. Previous affiliations of Mary Jo O'Sullivan include University of Texas Southwestern Medical Center & Wayne State University.
Papers
More filters
Journal ArticleDOI
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial
Garnet L. Anderson,Marian C. Limacher,Annlouise R. Assaf,Tamsen Bassford,Shirley A.A. Beresford,Henry R. Black,Denise E. Bonds,Robert L. Brunner,Robert G. Brzyski,Bette J. Caan,Rowan T. Chlebowski,J. David Curb,Margery Gass,Jennifer Hays,Gerardo Heiss,Susan L. Hendrix,Barbara V. Howard,Judith Hsia,F. Allan Hubbell,Rebecca D. Jackson,Karen C. Johnson,Howard L. Judd,Jane Morley Kotchen,Lewis H. Kuller,Andrea Z. LaCroix,Dorothy S. Lane,Robert Langer,Norman L. Lasser,Cora E. Lewis,JoAnn E. Manson,Karen L. Margolis,Judith K. Ockene,Mary Jo O'Sullivan,Lawrence S. Phillips,Ross L. Prentice,Cheryl Ritenbaugh,John A Robbins,Jacques E. Rossouw,Gloria E. Sarto,Marcia L. Stefanick,Linda Van Horn,Jean Wactawski-Wende,Robert B. Wallace,Sylvia Wassertheil-Smoller +43 more
TL;DR: The use of conjugated equine estrogen (CEE) increases the risk of stroke, decreases therisk of hip fracture, and does not affect CHD incidence in postmenopausal women with prior hysterectomy over an average of 6.8 years, indicating no overall benefit.
Journal ArticleDOI
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Edward M. Connor,Rhoda S. Sperling,Richard D. Gelber,Pavel Kiselev,Gwendolyn B. Scott,Mary Jo O'Sullivan,Russell Vandyke,Mohammed Bey,William T. Shearer,Robert L. Jacobson,Eleanor Jimenez,Edward O’neill,Brigitte Bazin,Jean François Delfraissy,Mary Culnane,Robert W. Coombs,Mary Elkins,Jack Moye,Pamela Stratton,James Balsley +19 more
TL;DR: In pregnant women with mildly symptomatic HIV disease and no prior treatment with antiretroviral drugs during the pregnancy, a regimen consisting of zidovudine given ante partum and intra partum to the mother and to the newborn for six weeks reduced the risk of maternal-infant HIV transmission by approximately two thirds.
Journal ArticleDOI
Calcium plus vitamin D supplementation and the risk of fractures.
Rebecca D. Jackson,Andrea Z. LaCroix,Margery Gass,Robert B. Wallace,John A Robbins,Cora E. Lewis,Tamsen Bassford,Shirley A.A. Beresford,Henry R. Black,Patricia L. Blanchette,Denise E. Bonds,Robert L. Brunner,Robert G. Brzyski,Bette J. Caan,Jane A. Cauley,Rowan T. Chlebowski,Steven R. Cummings,Iris A. Granek,Jennifer Hays,Gerardo Heiss,Susan L. Hendrix,Barbara V. Howard,Judith Hsia,F. Allan Hubbell,Karen C. Johnson,Howard L. Judd,Jane Morley Kotchen,Lewis H. Kuller,Robert Langer,Norman L. Lasser,Marian C. Limacher,Shari E. Ludlam,JoAnn E. Manson,Karen L. Margolis,Joan McGowan,Judith K. Ockene,Mary Jo O'Sullivan,Lawrence S. Phillips,Ross L. Prentice,Gloria E. Sarto,Marcia L. Stefanick,Linda Van Horn,Jean Wactawski-Wende,Evelyn P Whitlock,Garnet L. Anderson,Annlouise R. Assaf,David H. Barad +46 more
TL;DR: Among healthy postmenopausal women, calcium with vitamin D supplementation resulted in a small but significant improvement in hip bone density, did not significantly reduce hip fracture, and increased the risk of kidney stones.
Journal ArticleDOI
Maternal morbidity associated with multiple repeat cesarean deliveries
Robert M. Silver,Mark B. Landon,Dwight J. Rouse,Kenneth J. Leveno,Catherine Y. Spong,Elizabeth Thom,Atef H. Moawad,Steve N. Caritis,Margaret Harper,Ronald J. Wapner,Yoram Sorokin,Menachem Miodovnik,Marshall W. Carpenter,Alan M. Peaceman,Mary Jo O'Sullivan,Baha M. Sibai,Oded Langer,John M. Thorp,Susan M. Ramin,Brian M. Mercer +19 more
TL;DR: The number of intended pregnancies should be considered during counseling regarding elective repeat cesarean operation versus a trial of labor and when debating the merits of elective primary cESarean delivery.
Journal ArticleDOI
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.
Paul J. Meis,Mark A. Klebanoff,Elizabeth Thom,Mitchell P. Dombrowski,Baha M. Sibai,Atef H. Moawad,Catherine Y. Spong,John C. Hauth,Menachem Miodovnik,Menachem Miodovnik,Michael W. Varner,Kenneth J. Leveno,Steve N. Caritis,Jay D. Iams,Ronald J. Wapner,Deborah L. Conway,Mary Jo O'Sullivan,Marshall W. Carpenter,Brian M. Mercer,Susan M. Ramin,John M. Thorp,Alan M. Peaceman +21 more
TL;DR: In this paper, a double-blind, placebo-controlled trial involving pregnant women with a documented history of spontaneous preterm delivery was conducted, where women were enrolled at 19 clinical centers at 16 to 20 weeks of gestation.